David C. U'Prichard

David C. U'Prichard

Keine laufenden Positionen mehr
77 Jahre
Health Technology
Commercial Services
Finance

Profil

Dr. David C.
U'Prichard
is Independent cat Audeo Oncology, Inc., a Director at Anesiva, Inc., Founding Partner at Druid BioVentures LLC, Chairman at Cyclacel Pharmaceuticals, Inc., Venture Partner & Senior Advisor at Red Abbey Venture Partners LLC, Chairman at Orca Pharmaceuticals Ltd. and President at Druid Consulting LLC.
He is on the Board of Directors at Audeo Oncology, Inc., iCeutica, Inc., Anesiva, Inc., Angstrom Pharmaceuticals, Inc., BioMotiv LLC, Iroko Pharmaceuticals LLC, Iroko Pharmaceuticals, Inc., Ocimum Bio Solutions (India) Ltd., Ocimum Biosolutions, Inc., International House of Philadelphia and The Wilma Theater, Inc. Dr. U'Prichard was previously employed as Independent Director by Life Technologies Corp., Chairman by Cyclacel Group Plc, Chairman by Oxagen Ltd., Chairman by Pennsylvania Biotechnology Association, Venture Partner by Apax Partners (UK) Ltd., Chief Executive Officer & Director by 3-Dimensional Pharmaceuticals, Inc., Chairman-Research & Development by Smithkline Beecham Pharmaceuticals (India) Ltd., Executive Vice President-Biomedical Research by ICI Pharmaceuticals, Director, EVP & Director-International Research by Zeneca Group Plc, Scientific Director & Senior Vice President by Nova Pharmaceutical Corp., an Associate Professor by Feinberg School of Medicine, Venture Partner by Care Capital LLC, Venture Partner by Apax Partners, Inc., and Non-Executive Director by Silence Therapeutics Plc.
He also served on the board at Alpharma, Inc., Invitrogen Corp., Biotechnology Industry Organization, Atugen AG, CoGenesys, Inc., Guilford Pharmaceuticals, Inc., Life Sciences Research, Inc., Lynx Therapeutics, Inc., Naurex, Inc., Ocimum Bio Solutions (India) Ltd., Predict, Inc. and SMART Biosciences, Inc. He received his undergraduate degree from the University of Glasgow and a doctorate degree from the University of Kansas.

Ehemalige bekannte Positionen von David C. U'Prichard

UnternehmenPositionEnde
Churchill Pharmaceuticals
Direktor/Vorstandsmitglied 02.09.2020
Direktor/Vorstandsmitglied 02.09.2020
Direktor/Vorstandsmitglied 02.09.2020
Direktor/Vorstandsmitglied 02.09.2020
Direktor/Vorstandsmitglied 02.09.2020
Sehen Sie sich die Erfahrung von David C. U'Prichard im Detail an

Ausbildung von David C. U'Prichard

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

77

Beziehungen ersten Grades

49

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen49

Health Technology

Health Technology

Health Technology

Finance

Electronic Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Finance

Commercial Services

Finance

Consumer Services

Technology Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Services

Finance

Health Technology

Health Technology

Health Technology

Druid Consulting LLC

Commercial Services

Health Technology

Health Technology

Nova Pharmaceutical Corp.

Commercial Services

Health Technology

Commercial Services

Consumer Services

Consumer Services

Health Technology

Finance

Consumer Services

Technology Services

Finance

Churchill Pharmaceuticals

  1. Börse
  2. Insiders
  3. David C. U'Prichard